APO RESEARCH · REPORT
Targeted RNA Sequencing
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
Product & engineering
Understand the product.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Selected research
Industry Research
Targeted RNA Sequencing Industry Research Report 2026
Market perspective
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
Read the full market overview
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
Report Scope
This report quantifies the global Targeted RNA Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Targeted RNA Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Targeted RNA Sequencing Market by Company
Thermo Fisher
Illumina
Roche Holdings
BGI
Eurofins
LabCorp
Berry Genomics
Macrogen
GENEWIZ
Targeted RNA Sequencing Segment by Type
Exome Sequencing
Enrichment Sequencing
Amplicon Sequencing
Targeted RNA Sequencing Segment by Application
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
Targeted RNA Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeted RNA Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Targeted RNA Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeted RNA Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Targeted RNA Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Exome Sequencing
- Enrichment Sequencing
- Amplicon Sequencing
Applications
- Research Institutes
- Hospitals & Clinics
- Biotechnology Company
- Diagnostic Lab
Companies covered
- Thermo Fisher
- Illumina
- Roche Holdings
- BGI
- Eurofins
- LabCorp
- Berry Genomics
- Macrogen
- GENEWIZ
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Targeted RNA Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Exome Sequencing
- 2.2.3 Enrichment Sequencing
- 2.2.4 Amplicon Sequencing
- 2.3 Targeted RNA Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Research Institutes
- 2.3.3 Hospitals & Clinics
- 2.3.4 Biotechnology Company
- 2.3.5 Diagnostic Lab
- 2.4 Assumptions and Limitations
3 Targeted RNA Sequencing Breakdown Data by Type
- 3.1 Global Targeted RNA Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Targeted RNA Sequencing Forecasted Market Size by Type (2027-2032)
4 Targeted RNA Sequencing Breakdown Data by Application
- 4.1 Global Targeted RNA Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Targeted RNA Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Targeted RNA Sequencing Market Perspective (2021-2032)
- 5.2 Global Targeted RNA Sequencing Growth Trends by Region
- 5.2.1 Global Targeted RNA Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Targeted RNA Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Targeted RNA Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Targeted RNA Sequencing Market Dynamics
- 5.3.1 Targeted RNA Sequencing Industry Trends
- 5.3.2 Targeted RNA Sequencing Market Drivers
- 5.3.3 Targeted RNA Sequencing Market Challenges
- 5.3.4 Targeted RNA Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Targeted RNA Sequencing Players by Revenue
- 6.1.1 Global Top Targeted RNA Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Targeted RNA Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Targeted RNA Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Targeted RNA Sequencing Head Office and Area Served
- 6.4 Global Targeted RNA Sequencing Players, Product Type & Application
- 6.5 Global Targeted RNA Sequencing Manufacturers Established Date
- 6.6 Global Targeted RNA Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Targeted RNA Sequencing Market Size (2021-2032)
- 7.2 North America Targeted RNA Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Targeted RNA Sequencing Market Size by Country (2021-2026)
- 7.4 North America Targeted RNA Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Targeted RNA Sequencing Market Size (2021-2032)
- 8.2 Europe Targeted RNA Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Targeted RNA Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Targeted RNA Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Targeted RNA Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Targeted RNA Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Targeted RNA Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Targeted RNA Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Targeted RNA Sequencing Market Size (2021-2032)
- 10.2 South America Targeted RNA Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Targeted RNA Sequencing Market Size by Country (2021-2026)
- 10.4 South America Targeted RNA Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Targeted RNA Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Targeted RNA Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Targeted RNA Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher
- 12.1.1 Thermo Fisher Company Information
- 12.1.2 Thermo Fisher Business Overview
- 12.1.3 Thermo Fisher Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.1.4 Thermo Fisher Targeted RNA Sequencing Product Portfolio
- 12.1.5 Thermo Fisher Recent Developments
- 12.2 Illumina
- 12.2.1 Illumina Company Information
- 12.2.2 Illumina Business Overview
- 12.2.3 Illumina Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.2.4 Illumina Targeted RNA Sequencing Product Portfolio
- 12.2.5 Illumina Recent Developments
- 12.3 Roche Holdings
- 12.3.1 Roche Holdings Company Information
- 12.3.2 Roche Holdings Business Overview
- 12.3.3 Roche Holdings Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.3.4 Roche Holdings Targeted RNA Sequencing Product Portfolio
- 12.3.5 Roche Holdings Recent Developments
- 12.4 BGI
- 12.4.1 BGI Company Information
- 12.4.2 BGI Business Overview
- 12.4.3 BGI Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.4.4 BGI Targeted RNA Sequencing Product Portfolio
- 12.4.5 BGI Recent Developments
- 12.5 Eurofins
- 12.5.1 Eurofins Company Information
- 12.5.2 Eurofins Business Overview
- 12.5.3 Eurofins Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.5.4 Eurofins Targeted RNA Sequencing Product Portfolio
- 12.5.5 Eurofins Recent Developments
- 12.6 LabCorp
- 12.6.1 LabCorp Company Information
- 12.6.2 LabCorp Business Overview
- 12.6.3 LabCorp Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.6.4 LabCorp Targeted RNA Sequencing Product Portfolio
- 12.6.5 LabCorp Recent Developments
- 12.7 Berry Genomics
- 12.7.1 Berry Genomics Company Information
- 12.7.2 Berry Genomics Business Overview
- 12.7.3 Berry Genomics Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.7.4 Berry Genomics Targeted RNA Sequencing Product Portfolio
- 12.7.5 Berry Genomics Recent Developments
- 12.8 Macrogen
- 12.8.1 Macrogen Company Information
- 12.8.2 Macrogen Business Overview
- 12.8.3 Macrogen Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.8.4 Macrogen Targeted RNA Sequencing Product Portfolio
- 12.8.5 Macrogen Recent Developments
- 12.9 GENEWIZ
- 12.9.1 GENEWIZ Company Information
- 12.9.2 GENEWIZ Business Overview
- 12.9.3 GENEWIZ Revenue in Targeted RNA Sequencing Business (2021-2026)
- 12.9.4 GENEWIZ Targeted RNA Sequencing Product Portfolio
- 12.9.5 GENEWIZ Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst